Health Net 2001 Annual Report Download - page 44

Download and view the complete annual report

Please find page 44 of the 2001 Health Net annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 48

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48

SUPPLEMENTAL SCHEDULE I
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
(PARENT COMPANY ONLY) (Continued)
HEALTH NET, INC.
CONDENSED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
Year Ended December 31,
2001 2000 1999
Net Cash Flows from Operating Activities .................. $200,009 $ 98,574 $ 100,352
Cash Flows from Investing Activities:
Sales or maturities of investments ....................... 8,496 11,713 22,576
Purchases of investments ............................. (5,108) (9,121) (11,715)
Net purchases of property and equipment ................. (11,762) (32,312) (1,939)
Other assets ....................................... (15,311) (8,626) (6,124)
Cash received from the sale of businesses, net of cash disposed . — — 137,728
Net cash (used in) provided by investing activities ............. (23,685) (38,346) 140,526
Cash Flows from Financing Activities:
Proceeds from exercise of stock options and employee stock
purchases ....................................... 10,449 5,794 1,553
Proceeds from issuance of notes and other financing
arrangements .................................... 601,076 250,000 220,000
Repayment of debt .................................. (777,532) (522,807) (416,279)
Dividends received from subsidiaries ..................... 163,496 159,503 75,259
Capital contributions to subsidiaries ..................... (88,514) (45,525) (105,411)
Net cash used in financing activities ....................... (91,025) (153,035) (224,878)
Net increase (decrease) in cash and cash equivalents ........... 85,299 (92,807) 16,000
Cash and cash equivalents, beginning of period ............... 16,251 109,058 93,058
Cash and cash equivalents, end of period ................... $101,550 $ 16,251 $ 109,058
Supplemental Schedule of Non-Cash Investing and Financing
Activities:
Notes and stocks received on sale of businesses ............... 26,000 — 22,909
Settlement of intercompany notes payable through dividends from
subsidiaries ....................................... 62,337 — —
Settlement of intercompany notes receivable through capital
contributions to subsidiaries ........................... (55,063) (33,000) —
See accompanying note to condensed financial statements.
43